A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

Medically reviewed by Elizabeth Barnes, RDN Optimizing cognitive health is top of mind for many adults, and there are many ...

If you buy something, we may earn an affiliate commission. That’s not for us to say (or judge), but if you’ve heard about ...

Maintaining mental clarity, focus, and memory is essential to navigating daily life in a world where cognitive function is ...

In today’s fast-paced world, maintaining optimal cognitive function has become paramount. Whether juggling work deadlines, ...

The technology in question is brain-computer interface ... We want to deliver the best possible device on the safest possible timeline.” – Paradromics CEO Angle This year, the company got accepted ...

After considering the scientific substantiation, ingredient quality, and reported results of several high-grade testosterone support supplements, these 5 are among the best. These are ...

Hikma said on Monday it was “pleased to have FDA approval to launch this important medicine and to provide broader access and greater affordability for the patients who rely on it”.

Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...

We look forward to continuing to expand our portfolio, including the exploration of a next-generation brain-penetrant BRAF inhibitor.” The approval, conducted under the FDA's Project Orbis and Project ...

We look forward to continuing to expand our portfolio, including the exploration of a next-generation brain-penetrant BRAF inhibitor ... as detected by an FDA-approved test. This indication is ...